Clinical trial
A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
NCT00805441 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- July 31, 2009
- Enrollment
- 190 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence